Investing News

New Research Analysis Shows VINIA Reduces Oxidation Of LDL-Cholesterol To Support Cardiovascular Improved Functioning

New research analysis affirms the addition of the following structure function claims for VINIA® according to FDA Guidelines for Dietary Supplements:VINIA® prevents Lipid OxidationVINIA® protects the body by preventing oxidative damage to the cellsVINIA® reduces oxidation of LDL cholesterolBioHarvest Sciences Inc. reports that recent research analysis provides additional support for anti-oxidation ...

Markets
TSX	20633.27	-128.76
TSXV	897.13	-13.09
DOW	34580.08	-59.71
S&P 500	4538.43	-38.67
NASD	15085.47	-295.85
ASX	7241.20	+16.00

Markets

TSX

20633.27

-128.76

TSXV

897.13

-13.09

DOW

34580.08

-59.71

S&P 500

4538.43

-38.67

NASD

15085.47

-295.85

ASX

7241.20

+16.00

Commodities
Gold	1782.38	-0.55
Silver	22.49	-0.09
Copper	4.29	+0.02
Palladium	1810.46	-11.04
Platinum	940.00	+3.00
Oil	67.70	+1.44
Heating Oil	2.13	+0.03
Natural Gas	3.85	-0.28

Commodities

Gold

1782.38

-0.55

Silver

22.49

-0.09

Copper

4.29

+0.02

Palladium

1810.46

-11.04

Platinum

940.00

+3.00

Oil

67.70

+1.44

Heating Oil

2.13

+0.03

Natural Gas

3.85

-0.28

biotech Investing News

New Research Analysis Shows VINIA Reduces Oxidation Of LDL-Cholesterol To Support Cardiovascular Improved Functioning

4 Private Longevity Research Companies to Watch

BioHarvest Sciences Appoints Astronaut Chris Hadfield to the Board of Advisors

Top Canadian Biotech Stocks

Solarvest BioEnergy

Boosh Plant-Based Brands

Awakn Life Sciences Corp.

Virtual Care: The Next Step in the Evolution of Healthcare

Sirona Biochem CEO: Unique Opportunity for Global Success in the Cosmetic and Therapeutic Spaces

Awakn Life Sciences CEO Anthony Tennyson: Developing and Delivering the Next Generation of Addiction Treatments

How to Invest in Biotechnology

3 Alzheimer’s Disease Treatment Stocks on the NASDAQ

8 Top Oncology Companies

Solarvest Web Site Launched in Hong Kong to Service South Easy Asia

Beyond Medical Technologies Ramps Up COVID Mask Manufacturing in Response to New South Africa COVID Variant

Naturally Splendid Reports Third Quarter Results for 2021

Biotech Market Update: H1 2021 in Review

5 Top Biotech Companies by Market Cap

5 Small Biotech ETFs

MagicMed Industries

WellteQ Digital Health

HempFusion Wellness

Bristol Myers 24 Hour Deadline Alert: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits against Bristol-Myers Squibb Company - BMY

Bristol Myers 48 Hour Deadline Alert: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits against Bristol-Myers Squibb Company - BMY

Cohen Milstein Files Class Action Complaint Against Bristol-Myers Squibb Company

BRISTOL MYERS 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Bristol-Myers Squibb Company - BMY

AbbVie Provides Update on RINVOQ® for the Treatment of Rheumatoid Arthritis in the U.S.

Amgen Announces 10% Increase In 2022 First Quarter Dividend

U.S. Food and Drug Administration Accepts for Priority Review supplemental Biologics License Application for Reblozyl® in Adults with Non-Transfusion Dependent Beta Thalassemia

INVESTOR ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action Lawsuits filed on behalf of BMY, LSPD, PTON, ZG Investors, Lead Plaintiff Deadlines Set

CLAIMSFILER ALERTS BRISTOL MYERS Investors to Lead Plaintiff Deadline in Class Action Lawsuit Against Bristol-Myers Squibb Company - BMY

Amgen Announces Positive Top-Line Results From Otezla® Phase 3 DISCREET Study In Moderate To Severe Genital Psoriasis

FDA Approves New KYPROLIS® Combination Regimen With DARZALEX FASPRO® and dexamethasone For Patients With Multiple Myeloma At First Or Subsequent Relapse

FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BMY, CTXS, HEPS and STNE

MARKETS

COMMODITIES